Syros Pharmaceuticals is pioneering the understanding of the non-coding region of the genome to advance a new wave of medicines that control expression of disease-driving genes.

SYROS PHARMACEUTICALS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation or Organization) 45-3772460 (I.R.S. …

Re: Syros Pharmaceuticals, Inc. Registration Statement on Form S-3 (File No. 333-239141) Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the …

We would like to show you a description here but the site won’t allow us.